New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found that the biologic B-cell inhibitor belimumab was associated with a lower risk of severe infections and ...
Nov 8, 2022
0
2
Early diagnosis of chronic kidney disease (CKD) is key to managing progression of the disease. A new technique analyzing urine extracellular vesicles (uEVs)—cell-derived nanoscale spherical structures involved in multiple ...
Nov 8, 2022
0
43
Researchers from the RTI-University of North Carolina (UNC) Evidence-based Practice Center, Research Triangle Park, NC developed a 3-step process to help health care systems identify high-need, high-cost (HNHC) patients. ...
Nov 8, 2022
0
2
SGLT-2 inhibitors, a type of diabetes medicine, decreased cardiovascular risk among adults with chronic kidney disease, according to late-breaking research presented today at the American Heart Association's Scientific Sessions ...
Nov 7, 2022
0
16
Individuals with chronic kidney disease (CKD) are vulnerable to developing severe forms of COVID-19, and acute kidney injury is a common complication of COVID-19. A recent analysis examined the temporal effects of pre-existing ...
Nov 7, 2022
0
17
Both genetic and environmental factors contribute to chronic kidney disease (CKD). New research assessed the interaction of air pollution and genetic factors on the development of CKD. The research will be presented at ASN ...
Nov 4, 2022
0
13
Serious kidney-related complications—or major adverse kidney events—are common after hospitalization for various medical problems. Investigators have now developed and validated an artificial intelligence-based algorithm ...
Nov 3, 2022
0
5
New research has demonstrated a link between kidney disease and the development of cognitive problems. The findings will be presented at ASN Kidney Week 2022 November 3–6.
Nov 3, 2022
0
16
The burden of chronic kidney disease (CKD) to both health care systems and patients is considerable. Dapagliflozin, a sodium-glucose cotransporter-2 inhibitor, has been shown to be an efficacious treatment for CKD in the ...
Nov 2, 2022
0
2
Taking a personalized approach to kidney disease screening for people with type 1 diabetes (T1D) may reduce the time that chronic kidney disease (CKD) goes undetected, according to a new analysis performed by the Epidemiology ...
Nov 2, 2022
0
11
